WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Pfizer

PfizerAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.

www.pfizer.com

Filters
List of articles in category Pfizer
Title Published Date
Alzheimer's Challenge 2012: seeking new tools to help improve Alzheimer's care 29 January 2012
Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon 17 January 2012
A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health 10 January 2012
Pfizer Receives FDA Approval to Extend Use of Prevnar 13® 01 January 2012
Prevent Pneumococcal Disease in Infants and Young Children in the World's Poorest Countries 18 December 2011
Pfizer Elects CEO Ian Read as Chairman of the Board 12 December 2011
Pfizer Completes Acquisition of Excaliard 04 December 2011
Pfizer to Acquire Excaliard Pharmaceuticals 22 November 2011
Pfizer Wins Corporate Citizenship Award For Global Health Partnerships Program 20 November 2011
Treatment with Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits 07 November 2011
Pfizer Reports Third-Quarter 2011 Results 01 November 2011
Pfizer Completes Acquisition Of Icagen 30 October 2011
Humana and Pfizer Form Research Partnership 13 October 2011
Pfizer Announces Licensing Agreement With Puma Biotechnology 06 October 2011
NABP and Pfizer Partner to Educate Patients About The Flood of Counterfeit Medicines Online 30 September 2011
U.S. Food And Drug Administration Approves Pfizer's XALKORI® (crizotinib) 29 August 2011
Pfizer Announces EMA Acceptance of Regulatory Submissions 22 August 2011
Pfizer Wins Viagra Patent Trial 15 August 2011
NCCN Receives $2M Educational Grant from Pfizer 04 August 2011
Pfizer Reports Second-Quarter 2011 Results 02 August 2011
  • Start
  • Prev
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
  • End

Business & Industry

  • GSK completes acquisition of Sierra Oncology
  • Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine
  • Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
  • New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta® (ofatumumab) had no evidence of disease activity (NEDA-3)
  • Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron

Research & Development

  • Inhalable COVID-19 vaccine shows promise in rodent model
  • Researchers discover new leukemia-killing compounds
  • Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by researchers
  • Biomarkers found that could be drug targets against a deadly form of brain cancer
  • COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure
  • Novel drug combo activates natural killer cell immunity to destroy cancer cells
  • Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Pfizer
  4. Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.